Volume : 10, Issue : 08, August – 2023
Title:
05.FORMULATION, CHARACTERIZATION, AND IN-VITRO EVALUATION OF FLOATING MICROSPHERES OF RASAGILINE MESYLATE
Authors :
Dr. H. Padmalatha, N.Jyothi Reddy, V. Meghana, B. Sandhya, Y. Vijaya Lakshmi, Y. Anusha, P.Anuradha
Systematic studies were conducted using two different polymers in different concentrations to prepare Rasagiline Mesylate Floating Microspheres. All the prepared systems were evaluated for the different properties. From the Preformulation studies for drug excipients compatibility, it was observed that no physical incompatibility existed between the drug and excipients.
All the four different formulations prepared contain drug about 97%-102%.
In vitro drug release profile indicated that drug release was retarded due to the presence of higher concentration of polymer. Formulation F2 has only 68%drug release in 9 hrs due to higher ratio of the polymer. Formulated Microspheres gave satisfactory results for various evaluation parameters like Angle of Repose, Drug Entrapment Efficiency, Scanning Electronic Microscopy and in vitro drug release.Comparing the two different Polymers such as HPMC and Chitosan provided better-sustained release characteristics with excellent in-vitro drug release. From the above results also indicated that at higher viscosity grades of polymer concentrations drug release was retarded greatly.
Key words: Formulation, Characterization, Vitro Evaluation, Floating Microspheres, Rasagiline Mesylate.
Cite This Article:
Please cite this article in press H. Padmalatha et al, Formulation, Characterization, And In-Vitro Evaluation Of Floating Microspheres Of Rasagiline Mesylate, Indo Am. J. P. Sci, 2023; 10 (08).
Number of Downloads : 10
References:
1. Reddy BV, Krishnaveni K. Formulation and evaluation of efavirenz microspheres. Der Pharmacia letters. 2015; 7(6):1-9.
2. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of pharmacy and pharmacology. 1992 Apr; 44(4):283-6.
3. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor B. Microsphere: A review. Int. J. Res. Pharm. Chem. 2011;1(4):1184-98.
4. Virmani T, Gupta J. Pharmaceutical application of microspheres: an approach for the treatment of various diseases. Int J Pharm Sci Res. 2017; 8(8):3253-60.
5. Li SP, Kowarski CR, Feld KM, Grim WM. Recent advances in microencapsulation technology and equipment. Drug Development and Industrial Pharmacy. 1988 Jan 1; 14(2-3):353-76.
6. Kreuter J, Nefzger M, Liehl E, CzokR VR. Microspheres–A Novel Approach in Drug Delivery System. J Pharm sci. 1983; 72:1146.
7. Margel S, Wiesel E. Acrolein polymerization: monodisperse, homo, and hybrido microspheres, synthesis, mechanism, and reactions. Journal of Polymer Science: Polymer Chemistry Edition. 1984 Jan; 22(1):145-58.
8. Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chemical and Pharmaceutical Bulletin. 1981 Nov 25; 29(11):3363-8.
9. Patel NR, Patel DA, Bharadia PD, Pandya V, Modi D. Microsphere as a novel drug delivery. International Journal of Pharmacy & Life Sciences. 2011 Aug 1; 2(8).
10. Toshio Y, Mitsuru H, Shozo M, Hitoshi S. Specific delivery of mitomycin c to the liver, spleen and lung: Nano-and m1crospherical carriers of gelatin. International Journal of Pharmaceutics. 1981 Apr 1;8(2):131-41.
11. Patel NR, Patel DA, Bharadia PD, Pandya V, Modi D. Microsphere as a novel drug delivery. International Journal of Pharmacy & Life Sciences. 2011 Aug 1;2(8).
12. Herfarth H, Obermeier F, Andus T, Rogler G, Nikolaus S, Kuehbacher T, Schreiber S. Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn’s disease. The American journal of gastroenterology. 2002 Oct 1;97(10):2688.
13. Kavita K, Ashvini VR, Ganesh NS. Albumin microspheres. Unique system as drug delivery carriers for non steroidal anti-inflammatory drugs. Int J Pharm Sci Rev Res. 2010; 5(2):10.
14. Virmani T, Gupta J. Pharmaceutical application of microspheres: an approach for the treatment of various diseases. Int J Pharm Sci Res. 2017; 8(8):3253-60.
15. Gullotti E, Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Molecular pharmaceutics. 2009 Aug 3; 6(4):1041-51.
16. Alagusundaram M, Chetty MS, Umashankari K, Badarinath AV, Lavanya C, Ramkanth S. Microspheres as a novel drug delivery system: A review. Int J Chem Tech Res. 2009 Jul; 1(3):526-34.
17. Rathore B, Yadav A, Nayak G, Saraogi GK, Singhai AK. A review on microspheres as drug delivery carriers for management of diabetes mellitus. International journal of pharmacy & life sciences. 2012 Oct 1; 3(10).
18. Prasad BS, Gupta VR, Devanna N, Jayasurya K. Microspheres as drug delivery system-a review. J Glob Trends Pharm Sci. 2014; 5(3):1961-72.